Institute of Cancer Research: Royal Cancer Hospital (The)
Institute of Cancer Research: Royal Cancer Hospital (The)
Trading as: Institute of Cancer Research
#00534147 • Active
B2bServices
The Institute of Cancer Research, London, is a leading cancer research organization dedicated to making discoveries that defeat cancer. With a strong focus on innovative research and collaboration, they aim to improve cancer treatment and patient outcomes.
Founded: 04/06/1954
Industries: Other research and experimental development on natural sciences and engineering
Website: https://icr.ac.uk
Phone: Subscribe to view
Email: Subscribe to view
Location: Sutton
Products
- Cancer Treatment Strategies
- Research Publications
- Training Programs For Clinicians
Services
- Cancer Research
- Clinical Trials
- Phd Programs
Financial Snapshot
Last accounts made up to 31 July 2024
Next accounts due 30 April 2026 (11 months)
Cash in Bank £9.36m
↓ -17%
Turnover £138.64m
↓ -14%
EBITDA £12.06m
↑ 149%
Total Liabilities £27.05m
↓ -10%
Employees 1,170
↓ -8%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Amy Berrington | Group Leader, Genetics & Epidemiology, Icr | 17/07/2024 | British | 52 years |
| Ricardo Minaya Sainz | Student | 01/03/2024 | Mexican,spanish | 29 years |
| Carolin Madeleine Barth | Md, Director | 01/10/2023 | Swiss,german | 51 years |
| Nigel Philip Jones | Certified Chartered Accountant | 01/08/2023 | British | 60 years |
| Anthony James Clare | Lawyer | 01/08/2023 | British | 55 years |
| Margaret Frame | Academic | 01/03/2023 | British | 68 years |
| Christopher Richard Molloy | Company Director | 01/09/2022 | British | 57 years |
| Kristian Helin | Ceo | 01/09/2021 | Danish | 63 years |
| Julia Clare Buckingham | Trustee | 01/08/2021 | British | 74 years |
| John Charles Shakeshaft | Non Executive | 01/06/2021 | British | 71 years |
| Charles Jonathan Foreman | Financial Adviser | 01/10/2020 | British | 62 years |
| Karl Munslow Ong | Chief Operating Officer | 01/03/2019 | British | 45 years |
| Nicholas Clwyd Jones | Director | 01/11/2017 | British | 74 years |
| Clare Margaret Isacke | Research Scientist | 01/08/2013 | United Kingdom | 68 years |
| Caroline Ann Palmer | Chief Executive Royal Marsden | 15/06/1998 | British | 67 years |
Role:
Group Leader, Genetics & Epidemiology, Icr
Appointed:
17/07/2024
Nationality:
British
Age:
52 years
Role:
Student
Appointed:
01/03/2024
Nationality:
Mexican,spanish
Age:
29 years
Role:
Md, Director
Appointed:
01/10/2023
Nationality:
Swiss,german
Age:
51 years
Role:
Certified Chartered Accountant
Appointed:
01/08/2023
Nationality:
British
Age:
60 years
Role:
Lawyer
Appointed:
01/08/2023
Nationality:
British
Age:
55 years
Role:
Academic
Appointed:
01/03/2023
Nationality:
British
Age:
68 years
Role:
Company Director
Appointed:
01/09/2022
Nationality:
British
Age:
57 years
Role:
Ceo
Appointed:
01/09/2021
Nationality:
Danish
Age:
63 years
Role:
Trustee
Appointed:
01/08/2021
Nationality:
British
Age:
74 years
Role:
Non Executive
Appointed:
01/06/2021
Nationality:
British
Age:
71 years
Role:
Financial Adviser
Appointed:
01/10/2020
Nationality:
British
Age:
62 years
Role:
Chief Operating Officer
Appointed:
01/03/2019
Nationality:
British
Age:
45 years
Role:
Director
Appointed:
01/11/2017
Nationality:
British
Age:
74 years
Role:
Research Scientist
Appointed:
01/08/2013
Nationality:
United Kingdom
Age:
68 years
Role:
Chief Executive Royal Marsden
Appointed:
15/06/1998
Nationality:
British
Age:
67 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality | |
|---|---|---|---|---|
| No active PSCs found | ||||
No active PSCs found
Financial Accounts
| Jul 2023 | Jul 2022 | Jul 2021 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
3 charges registered
Midland Bank PLC Outstanding
Created 28/05/1999By way of first fixed charge all right title and interest in and to the account and the additional f...
Antiquarius Limited Outstanding
Created 18/07/1997The said deposit of £6,500.00 with any additions together with the interest bearing account to which...
Properties
3 properties
Regions
2
Freehold
1
Leasehold
2
GREATER LONDON
East Wing, First Floor, Centre for Molecular Pathology, Royal Marsden Hospital, Cotswold Road, Sutton
Leasehold
Added 20/12/2022 • SUTTON
GREATER LONDON
Radiopharmaceutical Production Unit at the Royal Marsden Hospital, Sutton
Leasehold
Added 03/09/2010 • SUTTON
SOUTH EAST
Land at Pollards Wood, Nightingales Lane, Chalfont St Giles
Freehold
Added 20/11/2015 • BUCKINGHAMSHIRE
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 07/04/2025 | Incorporation | Memorandum Articles | View (21 pages) |
| 07/04/2025 | Resolution | Resolution | View (1 page) |
| 20/12/2024 | Accounts | Accounts With Accounts Type Group | View (49 pages) |
| 11/12/2024 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
| 10/12/2024 | Officers | Termination Director Company With Name Termination Date | View (1 page) |
| 30/07/2024 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |
| 23/07/2024 | Officers | Termination Director Company With Name Termination Date | View (1 page) |